Intuitive Surgical (ISRG) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $2.80
- EPS estimate
- $2.51
- EPS surprise
- +11.50%
- Revenue surprise
- +2.37%
- Revenue
- $2.9B
- Revenue estimate
- $2.8B
- Reported
- Jul 16, 2026
Intuitive Surgical reported Q2 2026 results on July 16, 2026. Earnings per share came in at $2.80, ahead of the $2.51 estimate by 11.50%. Revenue was $2.9 billion, above the $2.8 billion consensus. Compared with Q2 2025, EPS rose about 27.9% from $2.19 and revenue rose about 20.8% from $2.4 billion.
The longer record shows consistent growth. Annual EPS rose every year in the table, from $4.69 in 2022 to $5.71 in 2023, $7.33 in 2024 and $8.93 in 2025, up about 90%. Full-year revenue rose from $6.3 billion in 2022 to $10.1 billion in 2025, up about 60%. The first half of 2026 adds up to $5.30 per share, about 32.5% more than the same period a year earlier. Q2 2026 set the EPS high in the table, and its revenue matched the $2.9 billion high from Q4 2025. Over the last 20 quarters, Intuitive Surgical beat the EPS estimate 18 times. The only misses were Q2 2022 and Q4 2022.
Intuitive Surgical reported Q3 between October 17 and October 21 in each of the past five years. That points to mid-to-late October 2026 for the next report. It will show whether the recent double-digit growth continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 16, 2026 | $2.51 | $2.80 | +11.50% | $2.9B | SEC |
| Q1 2026 | Apr 21, 2026 | $2.12 | $2.50 | +17.83% | $2.8B | SEC |
| Q4 2025 | Jan 22, 2026 | $2.25 | $2.53 | +12.50% | $2.9B | SEC |
| Q3 2025 | Oct 21, 2025 | $1.99 | $2.40 | +20.31% | $2.5B | SEC |
| Q2 2025 | Jul 22, 2025 | $1.93 | $2.19 | +13.62% | $2.4B | SEC |
| Q1 2025 | Apr 22, 2025 | $1.74 | $1.81 | +4.09% | $2.3B | SEC |
| Q4 2024 | Jan 23, 2025 | $1.79 | $2.21 | +23.32% | $2.4B | SEC |
| Q3 2024 | Oct 17, 2024 | $1.64 | $1.84 | +12.05% | $2.0B | SEC |
| Q2 2024 | Jul 18, 2024 | $1.54 | $1.78 | +15.45% | $2.0B | SEC |
| Q1 2024 | Apr 18, 2024 | $1.42 | $1.50 | +5.89% | $1.9B | SEC |
| Q4 2023 | Jan 23, 2024 | $1.48 | $1.60 | +7.82% | $1.9B | SEC |
| Q3 2023 | Oct 19, 2023 | $1.42 | $1.46 | +3.13% | $1.7B | SEC |
| Q2 2023 | Jul 20, 2023 | $1.33 | $1.42 | +6.82% | $1.8B | SEC |
| Q1 2023 | Apr 18, 2023 | $1.20 | $1.23 | +2.81% | $1.7B | SEC |
| Q4 2022 | Jan 24, 2023 | $1.25 | $1.23 | −1.69% | $1.7B | SEC |
| Q3 2022 | Oct 18, 2022 | $1.13 | $1.19 | +4.88% | $1.6B | SEC |
| Q2 2022 | Jul 21, 2022 | $1.20 | $1.14 | −4.78% | $1.5B | SEC |
| Q1 2022 | Apr 21, 2022 | $1.08 | $1.13 | +4.86% | $1.5B | SEC |
| Q4 2021 | Jan 20, 2022 | $1.28 | $1.30 | +1.68% | $1.6B | SEC |
| Q3 2021 | Oct 19, 2021 | $1.17 | $1.19 | +2.09% | $1.4B | SEC |
Quarterly revenue
Frequently asked questions
When did Intuitive Surgical (ISRG) last report earnings?
Intuitive Surgical last reported on Jul 16, 2026, covering fiscal Q2 2026.
Did ISRG beat earnings estimates?
Yes. Intuitive Surgical reported EPS of $2.80 for Q2 2026 against a $2.51 estimate — a 11.50% beat.
How much revenue did ISRG report last quarter?
Intuitive Surgical reported $2.9B in revenue for Q2 2026, against a consensus estimate of $2.8B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.